Cormorant Asset Management, LP Inspire Medical Systems, Inc. Transaction History

Cormorant Asset Management, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$207.57 - $280.17 $9.99 Million - $13.5 Million	-48,132 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$164.93 - $242.23 $6.08 Million - $8.93 Million	-36,868 Reduced 43.37%	48,132 $9.3 Million
Q1 2021 May 17, 2021	SELL	$182.45 - $249.25 $2.74 Million - $3.74 Million	-15,000 Reduced 15.0%	85,000 $17.6 Million
Q4 2020 Feb 16, 2021	SELL	$119.35 - $200.46 $2.39 Million - $4.01 Million	-20,000 Reduced 16.67%	100,000 $18.8 Million
Q3 2020 Nov 16, 2020	SELL	$87.5 - $130.91 $2.45 Million - $3.66 Million	-27,982 Reduced 18.91%	120,000 $15.5 Million

Q2 2020 Aug 14, 2020	SELL	$49.5 - $97.93 $99,891 - $197,622	-2,018 Reduced 1.35%	147,982 $12.9 Million
Q1 2020 May 15, 2020	SELL	$41.62 - $89.92 $928,126 - $2.01 Million	-22,300 Reduced 12.94%	150,000 $9.04 Million
Q3 2019 Nov 14, 2019	SELL	$61.02 - $70.19 $1.69 Million - $1.94 Million	-27,700 Reduced 13.85%	172,300 $10.5 Million
Q2 2019 Aug 14, 2019	SELL	$47.07 - $60.71 $2.35 Million - $3.04 Million	-50,000 Reduced 20.0%	200,000 $12.1 Million
Q1 2019 May 15, 2019	SELL	$39.48 - $62.0 $1.59 Million - $2.49 Million	-40,239 Reduced 13.86%	250,000 $14.2 Million
Q4 2018 Feb 14, 2019	SELL	$37.07 - $52.58 $361,840 - $513,233	-9,761 Reduced 3.25%	290,239 $12.3 Million
Q3 2018 Nov 14, 2018	SELL	$36.8 - $56.99 $919,999 - $1.42 Million	-25,000 Reduced 7.69%	300,000 $12.6 Million
Q2 2018 Aug 14, 2018	BUY	$24.05 - $39.5 $7.82 Million - $12.8 Million	325,000 New	325,000 $11.6 Million

369

26.6M

456K

620K

Ticker INSP
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 28,788,600
Market Cap $3.85B
Description
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for m...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.